Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
J Appl Microbiol ; 114(3): 877-85, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23167818

ABSTRACT

AIMS: The aim of this study is to evaluate the capacity of three bacteriocin producers, namely Lactococcus lactis subsp. lactis biovar diacetylactis UL719 (nisin Z producer), L. lactis ATCC 11454 (nisin A producer) and Pediococcus acidilactici UL5 (pediocin PA-1 producer), and to grow and produce their active bacteriocins in Macfarlane broth, which mimics the nutrient composition encountered in the human large intestine. METHODS AND RESULTS: The three bacteriocin-producing strains were grown in Macfarlane broth and in De Man-Rogosa-Sharpe (MRS) broth. For each strain, the bacterial count, pH drop and production of organic acids and bacteriocins were measured for different period of time. The ability of the probiotic candidates to inhibit Listeria ivanovii HPB 28 in co-culture in Macfarlane broth was also examined. Lactococcus lactis subsp. lactis biovar diacetylactis UL719, L. lactis ATCC 11454 and Ped. acidilactici UL5 were able to grow and produce their bacteriocins in MRS broth and in Macfarlane broth. Each of the three candidates inhibited L. ivanovii HPB 28, and this inhibition activity was correlated with bacteriocin production. The role of bacteriocin production in the inhibition of L. ivanovii in Macfarlane broth was confirmed for Ped. acidilactici UL5 using a pediocin nonproducer mutant. CONCLUSIONS: The data provide some evidence that these bacteria can produce bacteriocins in a complex medium with carbon source similar to those found in the colon. SIGNIFICANCE AND IMPACT OF THE STUDY: This study demonstrates the capacity of lactic acid bacteria to produce their bacteriocins in a medium simulating the nutrient composition of the large intestine.


Subject(s)
Bacteriocins/biosynthesis , Lactococcus lactis/metabolism , Pediococcus/metabolism , Probiotics , Coculture Techniques , Culture Media/chemistry , Humans , Intestine, Large/chemistry , Intestine, Large/microbiology , Lactic Acid/biosynthesis , Lactococcus lactis/growth & development , Listeria/drug effects , Nisin/analogs & derivatives , Nisin/biosynthesis , Pediocins , Pediococcus/growth & development
2.
J Appl Microbiol ; 107(4): 1298-307, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19486401

ABSTRACT

AIM: To investigate the nisin Z innocuity using normal human gingival fibroblast and epithelial cell cultures, and its synergistic effect with these gingival cells against Candida albicans adhesion and transition from blastospore to hyphal form. METHODS AND RESULTS: Cells were cultured to 80% confluence and infected with C. albicans in the absence or presence of various concentrations of nisin Z. Our results indicate that only high concentrations of nisin Z promoted gingival cell detachment and differentiation. Determination of the LD(50) showed that the fibroblasts were able to tolerate up to 80 microg ml(-1) for 24 h, dropping thereafter to 62 mug ml(-1) after 72 h of contact, compared to 160 microg ml(-1) after 24 h, and 80 microg ml(-1) after 72 h recorded by the gingival epithelial cells which displayed a greater resistance to nisin Z. The use of nisin Z even at low concentration (25 microg ml(-1)) at appropriate concentrations with gingival cells significantly reduced C. albicans adhesion to gingival monolayer cultures and inhibited the yeast's transition. CONCLUSION: These findings show that when used at non-toxic levels for human cells, nisin Z can be effective against C. albicans adhesion and transition and may synergistically interact with gingival cells for an efficient resistance against C. albicans. SIGNIFICANCE AND IMPACT OF THE STUDY: This study suggests the potential usefulness of nisin Z as an antifungal agent, when used in an appropriate range.


Subject(s)
Antifungal Agents/pharmacology , Candida albicans/drug effects , Gingiva/drug effects , Nisin/analogs & derivatives , Candida albicans/growth & development , Candida albicans/ultrastructure , Candidiasis, Oral/microbiology , Candidiasis, Oral/pathology , Cell Adhesion/drug effects , Cell Differentiation/drug effects , Cells, Cultured , Epithelial Cells/drug effects , Fibroblasts/drug effects , Gingiva/cytology , Gingiva/growth & development , Humans , Hyphae/growth & development , Lethal Dose 50 , Microbial Sensitivity Tests , Nisin/pharmacology
3.
J Appl Microbiol ; 105(5): 1630-9, 2008 Nov.
Article in English | MEDLINE | ID: mdl-19146497

ABSTRACT

AIMS: To investigate the efficacy of nisin Z, an antimicrobial peptide produced by certain strains of Lactococcus lactis against Candida albicans growth and transition. METHODS AND RESULTS: Candida albicans was cultured in the presence of various concentrations of nisin Z (1000, 500, and 100 microg ml(-1)) for different time points. Candida albicans growth was determined using the Alamar Blue assay. The yeast's transition from blastospore to hyphal form was assessed through optical microscope observations. The effect of nisin Z on C. albicans ultrastructure was followed by scanning and transmission electron microscopy. Our results show that nisin Z inhibited C. albicans growth beginning at 500 microg ml(-1). This inhibition was both time- and dose-dependent. Nisin Z was also active against C. albicans transition by significantly inhibiting the transformation of C. albicans from the blastospore to hyphal form. Treatments with nisin Z lead to ultrastructural disturbances of C. albicans. CONCLUSION: Our findings indicate that nisin Z significantly reduced C. albicans growth and transition. These effects may have occurred through ultrastructural modifications of this yeast. SIGNIFICANCE AND IMPACT OF THE STUDY: For the first time, effect of nisin Z on C. albicans was investigated. These results therefore suggest that nisin Z may have antifungal properties, and could be used as an antifungal molecule.


Subject(s)
Anti-Bacterial Agents/pharmacology , Antifungal Agents/pharmacology , Candida albicans/drug effects , Nisin/analogs & derivatives , Candida albicans/growth & development , Candida albicans/ultrastructure , Cells, Cultured/drug effects , Colony Count, Microbial , Dose-Response Relationship, Drug , Hyphae/growth & development , Microscopy, Electron, Scanning Transmission , Nisin/pharmacology , Time Factors
4.
Antimicrob Agents Chemother ; 51(1): 169-74, 2007 Jan.
Article in English | MEDLINE | ID: mdl-17060530

ABSTRACT

The effects of acid, oxgall, and H(2)O(2) on susceptibilities to antibiotics and nisin were examined for 13 strains of bifidobacteria. Susceptibilities to ampicillin, cloxacillin, penicillin, vancomycin, kanamycin, neomycin, paramomycin, streptomycin, chloramphenicol, erythromycin, tetracycline, and nisin A were assayed by a microdilution broth method. Acid-, oxgall- and H(2)O(2)-stressed variants were produced and assayed. Exposure to a pH of 2.0 for 60 min reduced susceptibilities to cloxacillin and nisin A but increased susceptibilities to ampicillin, vancomycin, aminoglycosides, chloramphenicol, and erythromycin in a strain-dependent manner. Exposure to oxgall (0.3%) for 90 min increased susceptibilities to cell wall-directed antibiotics and aminoglycosides but increased resistances to tetracycline and nisin A. Oxidative stress increased the susceptibilities of 70% of the strains to ampicillin and chloramphenicol, of 50% of the strains to cloxacillin and tetracycline, and of 40% of the strains to erythromycin but did not affect susceptibilities to vancomycin, kanamycin, and nisin A. This study shows that exposure of bifidobacteria to stressful conditions resembling those in the gastrointestinal tract may substantially modify their susceptibilities to antibiotics and may thus affect their probiotic capacities, especially when they are used for the management of intestinal infections and antibiotic-associated diarrhea.


Subject(s)
Acids/pharmacology , Anti-Bacterial Agents/pharmacology , Bifidobacterium/drug effects , Hydrogen Peroxide/pharmacology , Ampicillin/pharmacology , Bifidobacterium/classification , Chloramphenicol/pharmacology , Cloxacillin/pharmacology , Culture Media/pharmacology , Drug Resistance, Bacterial , Erythromycin/pharmacology , Microbial Sensitivity Tests , Nisin/pharmacology , Penicillins/pharmacology , Species Specificity , Tetracyclines/pharmacology , Vancomycin/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...